granisetron hydrochloride- granisetron hydrochloride tablet, film coated
teva pharmaceuticals usa, inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride tablets are contraindicated in patients with known hypersensitivity to the drug or any of its components. manufactured in israel by: teva pharmaceutical ind. ltd. jerusalem, 9777402, israel manufactured for: teva pharmaceuticals usa, inc. north wales, pa 19454 rev. f 2/2016
kytril film coated tablet 1 milligram
profind wholesale ltd. - granisetron hydrochloride - film coated tablet - 1 milligram
zofran 4 milligram film coated tablet
b & s healthcare - ondansetron hydrochloride dihydrate - film coated tablet - 4 milligram - serotonin (5ht3) antagonists
zofran 4 milligram film coated tablet
glaxosmithkline (ireland) limited - ondansetron hydrochloride - film coated tablet - 4 milligram
zofran 8 milligram film coated tablet
glaxosmithkline (ireland) limited - ondansetron hydrochloride - film coated tablet - 8 milligram
zofran 8 milligram film coated tablet
b & s healthcare - ondansetron hydrochloride dihydrate - film coated tablet - 8 milligram - serotonin (5ht3) antagonists
zofran 4 milligram film coated tablet
novartis pharmaceuticals uk ltd - ondansetron hydrochloride - film coated tablet - 4 milligram - serotonin (5ht3) antagonists
zofran 8 milligram film coated tablet
novartis pharmaceuticals uk ltd - ondansetron hydrochloride - film coated tablet - 8 milligram - serotonin (5ht3) antagonists
kytril tablet 1 mg
dksh singapore pte. ltd. - granisetron hcl eqv granisetron - tablet, film coated - 1.12 mg (eqv 1 mg) - granisetron hcl eqv granisetron 1 mg
granisetron hydrochloride tablet
breckenridge pharmaceutical, inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets usp are indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride tablets are contraindicated in patients with known hypersensitivity to the drug or any of its components.